Johnson& Johnson sells more than $500 million worth of its COVID-19 vaccine in third quarter
October 19, 2021 at 08:40 AM EDT
Johnson & Johnson said Tuesday that it sold more than $500 million worth of its COVID-19 vaccine during the third quarter, surpassing what most experts anticipated.